ArticleCadernos de saude publica2026
Knowledge, attitudes and practices about dengue vaccines in Latin America and the Caribbean: a scoping review.
Article in Cadernos de saude publica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dengue remains a major public health concern in Latin America and the Caribbean, where vaccination has emerged as a key strategy to reduce severe disease. However, its successful implementation depends on population knowledge, attitudes, and practices (KAP). This study aimed to synthesize available evidence on KAP related to dengue vaccination in the region. A scoping review was conducted following JBI guidelines. Searches were performed in international and regional databases, including MEDLINE/PubMed, Scopus, Embase, Web of Science, SciELO, and the Virtual Health Library. Original studies were included without language or date restrictions. Study selection and data extraction were conducted independently and in duplicate. Sixteen studies were included. Most studies reported limited knowledge regarding vaccine availability, safety, and mechanisms of action. In contrast, attitudes were generally favorable, with high acceptance and willingness to pay, estimated at approximately USD 23 for a three-dose regimen. However, willingness to participate in clinical trials remained low due to safety and trust concerns. Evidence from a study conducted in Puerto Rico indicated that the COVID-19 pandemic was associated with increased intention to receive the dengue vaccine. Practices were less studied, and findings showed low completion of vaccination schedules, indicating a gap between attitudes and uptake. Despite generally favorable attitudes, important knowledge gaps and implementation challenges persist. Strengthening educational strategies and promoting qualified communication between healthcare professionals and the population - particularly during the introduction of new vaccines and in the context of adverse events - may support informed decision-making and improve dengue vaccine uptake.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.